Real-world, 12-month results demonstrated efficacy, safety and durability for faricimab as a treatment for retinal vein ...
Retinal vein occlusion (RVO) is a severe disease that occurs when a vein in the light-sensitive layer at the back of the eye ...
European Commission grants marketing approval for Eylea 8 mg to treat macular edema following RVO, including branch, central and hemiretinal vein occlusion: Berlin Monday, January ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback